Benjamin D. Ehst

2.9k total citations · 1 hit paper
30 papers, 2.2k citations indexed

About

Benjamin D. Ehst is a scholar working on Immunology, Dermatology and Epidemiology. According to data from OpenAlex, Benjamin D. Ehst has authored 30 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Dermatology and 4 papers in Epidemiology. Recurrent topics in Benjamin D. Ehst's work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (9 papers) and Immunotherapy and Immune Responses (6 papers). Benjamin D. Ehst is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (9 papers) and Immunotherapy and Immune Responses (6 papers). Benjamin D. Ehst collaborates with scholars based in United States, Germany and China. Benjamin D. Ehst's co-authors include Marc K. Jenkins, Elizabeth Ingulli, Stephen J. McSorley, R. Lee Reinhardt, Andrea Itano, Alexander Y. Rudensky, Thomas S. Griffith, Yimin Yu, Edward E. Lemmens and Andrew T. Gewirtz and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Communications.

In The Last Decade

Benjamin D. Ehst

27 papers receiving 2.2k citations

Hit Papers

Distinct Dendritic Cell Populations Sequentially Present ... 2003 2026 2010 2018 2003 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Distinct Dendritic Cell Populations Sequentially Present Antigen to CD4 T Cells and Stimulate Different Aspects of Cell-Mediated Immunity
    2003 594 citations Andrea Itano, Stephen J. McSorley et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin D. Ehst United States 14 1.6k 384 290 252 243 30 2.2k
J.P. Vivian Australia 28 1.6k 1.0× 632 1.6× 415 1.4× 240 1.0× 74 0.3× 55 2.6k
Hideyuki Tomizawa Japan 17 2.7k 1.7× 666 1.7× 322 1.1× 664 2.6× 166 0.7× 24 3.6k
Fang‐Ping Huang United Kingdom 18 1.9k 1.2× 475 1.2× 231 0.8× 242 1.0× 60 0.2× 27 2.7k
Dong Soo Yu South Korea 26 790 0.5× 660 1.7× 328 1.1× 189 0.8× 217 0.9× 98 1.8k
Mamoru Kiniwa Japan 20 845 0.5× 235 0.6× 294 1.0× 147 0.6× 127 0.5× 64 1.8k
Takanori So Japan 30 2.0k 1.2× 753 2.0× 791 2.7× 170 0.7× 94 0.4× 78 3.0k
Lara S. Izotova United States 19 1.4k 0.9× 780 2.0× 894 3.1× 434 1.7× 95 0.4× 37 2.5k
Paul A Santini United States 8 1.0k 0.6× 524 1.4× 110 0.4× 129 0.5× 59 0.2× 12 1.7k
Barbara Boone Belgium 15 423 0.3× 582 1.5× 401 1.4× 223 0.9× 177 0.7× 24 1.6k
Linda Hibbert United Kingdom 13 1.4k 0.9× 259 0.7× 663 2.3× 257 1.0× 177 0.7× 15 2.0k

Countries citing papers authored by Benjamin D. Ehst

Since Specialization
Citations

This map shows the geographic impact of Benjamin D. Ehst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin D. Ehst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin D. Ehst more than expected).

Fields of papers citing papers by Benjamin D. Ehst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin D. Ehst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin D. Ehst. The network helps show where Benjamin D. Ehst may publish in the future.

Co-authorship network of co-authors of Benjamin D. Ehst

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin D. Ehst. A scholar is included among the top collaborators of Benjamin D. Ehst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin D. Ehst. Benjamin D. Ehst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Blauvelt, Andrew, Lam C. Tsoi, Mehrnaz Gharaee‐Kermani, et al.. (2025). A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumab. Nature Communications. 17(1). 733–733.
3.
Buhl, Timo, Andrea S. Bauer, Benjamin D. Ehst, et al.. (2025). Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream. Dermatology and Therapy. 15(5). 1181–1193.
4.
Gold, Linda Stein, J.Q. Del Rosso, Benjamin D. Ehst, et al.. (2025). Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials. Journal of Dermatological Treatment. 36(1). 2444489–2444489. 2 indexed citations
5.
Blauvelt, Andrew, Andrea Chiricozzi, Benjamin D. Ehst, & Mark Lebwohl. (2023). Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review. Advances in Therapy. 40(8). 3410–3433. 34 indexed citations
6.
Menter, Alan, Tina Bhutani, Benjamin D. Ehst, Boni E. Elewski, & Abby Jacobson. (2022). Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis. Dermatology and Therapy. 12(6). 1289–1302. 13 indexed citations
7.
Armstrong, April W., Bruce Strober, Benjamin D. Ehst, & Abby Jacobson. (2020). 15921 Absolute PASI response up to 52 weeks with brodalumab in patients with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 83(6). AB164–AB164. 4 indexed citations
8.
Siegel, Sarah, Kevin Winthrop, Benjamin D. Ehst, & Alex G. Ortega‐Loayza. (2017). 191 Secukinumab treatment of individuals with psoriasis infected with hepatitis B and/or hepatitis C virus. Journal of Investigative Dermatology. 137(5). S32–S32. 1 indexed citations
9.
Patel, Anisha B., Alvin R. Solomon, Michael J. Mauro, & Benjamin D. Ehst. (2015). Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Dermatology. 232(1). 122–125. 28 indexed citations
10.
Simpson, Brenda, et al.. (2014). Triple antibiotic combination therapy may improve but not resolve granuloma annulare. Dermatologic Therapy. 27(6). 343–347. 9 indexed citations
11.
12.
O’Hearn, Mary, et al.. (2012). Chronic Ulcerative Herpes Simplex Virus Infection of the Vulva. Case Reports in Dermatology. 4(3). 192–196. 1 indexed citations
13.
Ehst, Benjamin D., et al.. (2010). Cutaneous Manifestations of Internal Malignancy. Current Problems in Surgery. 47(5). 384–445. 28 indexed citations
14.
Fonder, Margaret A., Deborah L. Cummins, Benjamin D. Ehst, Grant J. Anhalt, & Jon H. Meyerle. (2006). Adalimumab therapy for recalcitrant pyoderma gangrenosum.. PubMed. 5. e8–e8. 55 indexed citations
15.
Janssen, Edith M., Nathalie Droin, Edward E. Lemmens, et al.. (2005). CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature. 434(7029). 88–93. 490 indexed citations
16.
17.
Ehst, Benjamin D., Elizabeth Ingulli, & Marc K. Jenkins. (2003). Development of a Novel Transgenic Mouse for the Study of Interactions Between CD4 and CD8 T Cells During Graft Rejection. American Journal of Transplantation. 3(11). 1355–1362. 168 indexed citations
18.
Itano, Andrea, Stephen J. McSorley, R. Lee Reinhardt, et al.. (2003). Distinct Dendritic Cell Populations Sequentially Present Antigen to CD4 T Cells and Stimulate Different Aspects of Cell-Mediated Immunity. Immunity. 19(1). 47–57. 594 indexed citations breakdown →
19.
McSorley, Stephen J., Benjamin D. Ehst, Yimin Yu, & Andrew T. Gewirtz. (2002). Bacterial Flagellin Is an Effective Adjuvant for CD4+ T Cells In Vivo. The Journal of Immunology. 169(7). 3914–3919. 215 indexed citations
20.
Sperling, Anne I., Julie Auger, Benjamin D. Ehst, et al.. (1996). CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. The Journal of Immunology. 157(9). 3909–3917. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.P. Vivian Breakdown of academic impact, for papers by Hideyuki Tomizawa Breakdown of academic impact, for papers by Fang‐Ping Huang Breakdown of academic impact, for papers by Dong Soo Yu Breakdown of academic impact, for papers by Mamoru Kiniwa Breakdown of academic impact, for papers by Takanori So Breakdown of academic impact, for papers by Lara S. Izotova Breakdown of academic impact, for papers by Paul A Santini Breakdown of academic impact, for papers by Barbara Boone Breakdown of academic impact, for papers by Linda Hibbert
Rankless by CCL
2026